UNSPSC 85818801: Transfusion of autologous antihemophilic factors into central artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous antihemophilic factors into central artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30260V0

UNSPSC 85818801, Transfusion of autologous antihemophilic factors into central artery, open approach (Commodity), shows little relevant recent activity under its nominal medical procedure scope. The recent opportunities tagged to this code do not involve transfusion services or antihemophilic factor treatment; instead, state and local jurisdictions have posted solicitations for occupational medical surveillance, disability evaluation services, pharmacy benefit management, temporary health professional staffing, surgical center-of-excellence networks, and youth detention medical services. None of these represent the specialized hematologic intervention the code nominally describes. The mismatch suggests either systematic miscoding by issuing bodies or low procurement frequency for this particular procedure through state and local channels, making the code a poor targeting vehicle for vendors in this service line.

No current state and local procurement opportunities directly matching transfusion of autologous antihemophilic factors or closely aligned hematologic services appear in the recent solicitation record. Vendors pursuing work under this code should verify that issuing bodies in their target markets are correctly coding relevant opportunities, or consider that demand for this Commodity may route through different procurement channels (hospital group purchasing organizations, cooperative purchasing agreements, or specialty pharmacy benefit carve-outs) rather than direct state and local RFP or RFQ issuances.